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Commonly used implants for therapeutic approaches of non-systemically impaired bone do not sufficiently support
the healing process of osteoporotic bone. Since strontium (II) has been proven as an effective anti-osteoporotic
drug new types of strontium enriched calcium phosphate bone cements were developed. As osteoporosis is
characterized by an imbalance of osteoblast and osteoclast activity the influence of this newly generated strontium
enriched biomaterials on the cellular behavior of osteoblast-like cells was investigated by time of flight secondary
ion mass spectrometry (ToF-SIMS). ToF-SIMS is used to analyze whether strontium is incorporated in the mineralized
extracellular matrix (mECM) and whether there is strontium uptake by osteogenically differentiated human
mesenchymal stem cells (hMSCs). Therefore hMSCs were cultured in osteogenic differentiation medium for 21 days
on two different strontium enriched bone cements (S100 and A10) and for reference also on the pure calcium
phosphate cement (CPC) and on a silicon wafer. The distribution of strontium in the osteoblast-like cells and within
their mineralized extracellular matrix was analyzed. A higher intensity of the strontium signal could be detected in
the region of the mECM, synthesized by cells cultivated on the Sr- substituted bone cement (S100) in comparison
to the reference groups. The osteoblast-like cells used the released strontium from the biomaterial to synthesize
their mECM. Apart from that a uniform strontium distribution was measured within all investigated cells. However,
different amounts of strontium were found in cells cultured on different biomaterials and substrates. Compared to
the negative controls the strontium content in the cells on the strontium enriched biomaterials was much higher. A
higher concentration of strontium inside the cells means that more strontium can take part in signaling pathways.
As strontium is known for its beneficial effects on osteoblasts by promoting osteoblastic cell replication and
differentiation, and reducing apoptosis, the newly developed strontium enriched calcium phosphate cements are
promising implant materials for osteoporotic bone.
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Osteoporosis is the most common type of systemic
bone disease. It is characterized by reduction of bone
mineral density (BMD) and leads to an increased risk of
fracture [1]. Commonly used implants for therapeutic
approaches of non-systemically impaired bone are not
sufficient in supporting the healing process of damaged
osteoporotic bone regarding their chemical, biological* Correspondence: Marcus.Rohnke@phys.chemie.uni-giessen.de
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reproduction in any medium, provided the origand biomechanical properties [2]. Therefore implants and
biomaterials which are appropriate for the therapeutic use
in systemically altered bone are currently under deve-
lopment. Calcium phosphate cements, which have been
proposed to reinforce osteoporotic bone, are particularly
promising [3]. In general bone cements have been used
very successfully in the treatment of a wide range of bone
defects due to their biological beneficial behavior and
handling properties [4]. They perfectly fit into the bone
defect cavity or can be molded easily to the desired shape
[5]. It was proven that calcium phosphate materials also
allow ionic substitution, which offers another degree ofringer. This is an Open Access article distributed under the terms of the Creative
mmons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
inal work is properly cited.
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with specific activity and with biological relevance, such as
Mg2+ and Zn2+ can be added easily to the precursor mate-
rials [6]. Adding an agent with anti-osteoporotic effects
could improve the osseointegration of the implant which
would cause a better fracture healing [7]. Strontium ions
have been proven as an effective anti-osteoporotic drug
through their antiresorptive and bone-forming effects [8].
In vitro experiments showed that strontium enhances the
proliferation of preosteoblastic cells and bone matrix syn-
thesis [9]. And it was also found that it reduces the osteo-
clast activity [10]. Furthermore it has been demonstrated
that strontium is incorporated into mineralized nodules
without any negative effect on the formation of mineral-
ized matrix even in long-term treatment of osteoblast like
cells with strontium ranelate in the growth medium [11].
It has also been demonstrated that strontium stimulates
bone formation and decreases bone resorption in vivo
[12,13]. Clinical studies in postmenopausal osteoporotic
patients showed a beneficial effect of orally administered
strontium ranelate on fracture risk and micro architecture
[14,15]. Therefore strontium ranelate is increasingly used
in treatment strategies for osteoporosis [16]. Recently Li
et al. found an improvement of implant osseointegration
in osteoporotic rats, which had an additional oral dispense
of strontium ranelate [17]. But Leeuwenkamp et al.
showed that the bioavailability of orally administered
strontium is only about 20% [18]. Therefore, in order to
increase the local strontium dosage new types of stron-
tium enriched calcium phosphate bone cements have
recently been developed to achieve a local release of stron-
tium ions into the bone defect [19].
In this paper we report on the influence of these
strontium enriched biomaterials on the behavior of
osteoblast-like cells and the formation of their mineral-
ized extracellular matrix (mECM) as analyzed by time-
of-flight secondary ion mass spectrometry (ToF-SIMS).
ToF-SIMS is a highly surface-sensitive and chemically
specific analytical technique for both inorganic and
organic matter. A focused primary ion beam is used to
generate ionized molecular fragments from a solid
sample in ultra-high vacuum. These secondary ions are
then separated by their mass-to-charge ratio using a
time-of-flight mass analyzer [20,21]. By carefully
analyzing the mass spectrum the chemical composition
of the sample can be reconstructed. As the primary ion
beam can be rasterized across the sample surface an
image of the intensity distribution of a selected mass
signal can be obtained [22]. By using an additional ion
gun (sputter gun), which is much more intensive than
the analysis gun (primary ion gun), it is possible to
remove a small area of the sample layer by layer to get
three-dimensional mass information. This technique has
been applied to a wide range of materials. The developmentof polyatomic ion sources which cause less residual
damage of the ion-impacted surface in recent years
made it possible to investigate also biological samples
[23,24]. Major improvements were seen during the last
two decades, and currently the application of ToF-
SIMS to the analysis of tissue sections and single cells
is quickly advancing [25,26]. Several groups have
shown that ToF-SIMS is a powerful technique to
characterize cells [27] and to achieve 3D analysis of
cells [28-30]. It was also demonstrated that it is pos-
sible to investigate the mineralized extracellular matrix
of osteoblasts [31].
Here we use ToF-SIMS to investigate whether stron-
tium is incorporated in the mineralized extracellular
matrix (mECM) and whether there is strontium uptake
by osteogenically differentiated human mesenchymal
stem cells (hMSCs). Therefore the distribution of the
strontium mass signal in mineralized extracellular
matrix of osteoblast-like cells cultured on two different
strontium enriched bone cements was analyzed with
high spatial resolution. Also the strontium intensity in
the osteoblast-like cells relocated from the biomaterials
to silicon wafers was monitored, which may help to
understand the beneficial effect of strontium on osteo-
blasts better.
Methods
Cement modification with strontium (II)
Strontium (II) was introduced into a hydroxyapatite
forming, α-tricalcium phosphate based cement by (a)
the addition of strontium carbonate or by (b) complete
substitution of CaCO3 (a component of the standard ce-
ment precursor formulation) by SrCO3 as described in
detail elsewhere [19]. Briefly, cement precursor powder
(InnoTERE GmbH, Radebeul, Germany) was composed
of α-tricalcium phosphate (α-TCP), dicalcium phosphate
(monetite), calcium carbonate (CaCO3) and hydroxy-
apatite (HA). In substitution-type samples, CaCO3 was
replaced with SrCO3 (samples denoted as S100), whilst
10 wt-% SrCO3 were added to the precursor powder in
samples referred to as A10. Therefore, in S100 samples
a homogenous substitution of Ca2+- by Sr2+- ions could
be obtained, whereas A10 samples are characterised by
SrCO3 clusters embedded in a Sr-free cement matrix
[19]. Cylindrical samples of 10 mm diameter and
approx. 1 mm height were manually prepared by
moulding a paste prepared from the precursor powder
mixed with 400 μL g-1 4% Na2HPO4 (Sigma Aldrich,
Taufkirchen, Germany) solution in water. Samples were
cured for 4 days in water-saturated atmosphere at 37°C
and subsequently sterilised (γ-radiation, 25 kGy). A Sr-free
standard calcium phosphate cement (CPC) prepared
according to the same protocol was used as a control
material.
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Primary human mesenchymal stem cells (hMSC) isolated
from the bone marrow of 3 donors kindly provided by
the Medical Clinic I, Dresden University Hospital “Carl
Gustav Carus” (Prof. Martin Bornhäuser and co-
workers) were used after given consent. The ethics com-
mission of Technische Universität Dresden approved
application of hMSC for in vitro experiments. Cells
were cultured in α-MEM containing 9% fetal calf serum
(FCS), 10 U mL-1 penicillin, 100 μg mL-1 streptomycin
and 1% L-glutamine (all purchased from Biochrom,
Berlin, Germany) at 37°C and 5% CO2. Two different
types of cell samples were prepared. On the one hand
cells were seeded onto biomaterials (CPC, A10 and
S100) to study matrix formation and mineralization
in vitro. 2 · 104 cells of the 5th passage were cultured for
21 days in the presence of osteogenic supplements (10-8 M
dexamethasone, 5 mM β-glycerophosphate and 0.05 mM
ascorbic acid 2-phosphate, all purchased from Sigma
Aldrich, Taufkirchen, Germany). On the other hand
relocated cells were used to study the strontium content
inside the cells. Therefore cells cultured on cement
samples were detached using trypsin/EDTA (Invitrogen)
for 15 min, transferred to silicon wafers (Si-MAT,
Kaufering, Germany) and allowed to adhere for 24 h
(CPC r, B10 r, S100 r). Several control groups on silicon
wafers were also prepared. 2 · 104 cells of the 5th pas-
sage were seeded onto silicon wafers and cultured in
differentiation medium for one (Si1a-c) or 21 days (Si21d).
In case of some of the cells cultured on silicon wafers for
21 days, the medium was further supplemented with
0.1 mM (SrCl2 0.1) and 1.0 mM SrCl2 (SrCl2 1.0), respect-
ively. The strontium chloride was purchased from Sigma
Aldrich. One load of the cell samples cultured with
1.0 mM SrCl2 was relocated afterwards on a silicon wafer
(SrCl2 1.0 r). All cell samples were washed with phosphate
buffered saline (PBS, Invitrogen) and fixed with 3.7%
glutaraldehyde (Sigma Aldrich), dehydrated in ethanol
(VWR, Darmstadt, Germany) and subsequently critical-
point dried (CPD 030, Bal-Tec, Liechtenstein). Details of
all samples are summarized in Tables 1 and 2.
ToF-SIMS analysis
Pure cement samples and the critical-point dried cell
samples were used for ToF-SIMS analysis. ToF-SIMS
data were acquired using a TOF.SIMS 5 instrumentTable 1 Samples used to study incorporation of strontium in
Sample name Description
CPC m Pure CaP-bone cement.
A10 m CaP-bone cement with 10 wt-% SrCO3 added.
S100 m CaP-bone cement with SrCO3 substituting CaCO3.(ION-TOF, Münster, Germany) equipped with a 25 keV
bismuth primary ion-source and a 2 keV O2 sputter ion-
gun. To investigate the pure cements and the mECM of
the cement cultured cells, sample imaging was performed
within an area of 120 × 120 μm2 to 250 × 250 μm2 using
Bi3
+ cluster ions. Each scan provides an image with 128 ×
128 pixels and an approximate pixel size of 5–10 μm. The
target current was 0.3 pA - 0.4 pA and the ion dose dens-
ity was about 1∙1012 1/cm2. Images were recorded using
the high current bunch mode with high mass resolution
(m/Δm FWHM> 4000). For calibration the masses of the
molecules CH3
+, C2H3
+, C3H5
+ and C7H7
+ were used. To
compare the ToF-SIMS mass images with optical images
the 2D mode of a PLu neox 3D optical profiler (Sensofar,
Terrassa, Spain) equipped with a blue LED at 460 nm
wavelength was used.
For 3D-analysis of the osteoblast-like cells, cells were
relocated from the cements to silicon wafers to avoid
mixing effects close to the cement/cell interface. For the
3D-analysis the oxygen sputter gun was used because
further experiments have shown that strontium shows a
higher ionization rate by using O2
+ instead of C60
+ or Cs+.
The comparison between 3D profiles obtained by different
analytical methods showed that virtually no differential
sputtering occurred during the depth profiling using the
oxygen sputter gun (Additional file 1). O2
+
- sputtering was
performed on a 400 × 400 μm2 area with a kinetic energy
of 500 eV. The current at the target ranged between
90 nA - 100 nA. The analysis sequence included a sputter
cycle of 1 s followed by acquisition of 10 scans in high
current bunch mode in the respective crater center of
100 × 100 μm2. Data evaluation was performed using the
software TOF-SIMS Surface Lab 6.3 (ION-TOF GmbH,
Germany). For 3D reconstruction of the depth profiles the
NESAC/BIO toolbox ZCorrectorGUI based on MATLAB
was used [32].
In order to compare the relative intensities of the
strontium signal from the depth profiles of different
samples the following procedure was carried out:
1. Three adherent cells of each sample were depth
profiled using the same raster size, primary ion dose
per cycle (1∙1014 1/cm2), and sputter dose per cycle
(1∙1016 1/cm2).
2. For evaluating the data the same area size of region
of interest (ROI) was chosen for every cell and thethe mECM
hMSCs cultured in osteogenic differentiation medium for
21 days
21 days
21 days
Table 2 Samples used to compare the strontium content inside the osteogenically differentiated hMSCs
Sample name Description hMSCs cultured in osteogenic differentiation medium for
Si1d a No strontium addition. 1 day on a silicon wafer
Si1d b No strontium addition. 1 day on a silicon wafer
Si1d c No strontium addition. 1 day on a silicon wafer
Si21d No strontium addition. 21 days on a silicon wafer
CPC r Pure CaP-bone cement. 21 days on cement, relocated on a silicon wafer and cultured for one day.
A10 r CaP-bone cement with 10 wt -% SrCO3 added. 21 days on cement, relocated on a silicon wafer and cultured for one day.
100 r CaP-bone cement with SrCO3 substituting CaCO3. 21 days on cement, relocated on a silicon wafer and cultured for one day.
SrCl2 0.1 0.1 mM SrCl2 solution added to the medium 21 days on a silicon wafer
SrCl2 1.0 1.0 mM SrCl2 solution added to the medium 21 days on a silicon wafer
SrCl2 r 1.0 mM SrCl2 solution added to the medium 21 days, relocated on a silicon wafer and cultured for one day.
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strontium signal was summed up over 100 sputter
cycles from each profile and normalized to total
counts.
The cell size was determined using the 3D mode of
the PLu neox 3D optical profiler (Sensofar, Terrassa/
Spain). The thickness of the cells varies between 250 –
400 nm. This results in estimated sputter rates of 0.2 –
0.3 nm/s.
Results and discussion
A typical mass spectrum of an area on the strontium
substituted calcium phosphate cement cultured with
hMSCs in osteogenic differentiation medium for one day
(S100 1d) is shown in Figure 1 A1. In previous studies
characteristic mass signals of ToF-SIMS spectra origi-
nating from the cell membrane have been attributed un-
equivocally to characteristic biomolecules from the cells
[33]. These characteristic masses include m/z = 184 u,
being phosphatidylcholine, which is part (head group) of
the most abundant class of phospholipids in mammalian
cells. The m/z = 184 u ion (C5H15PNO4
+) has a characteris-
tic fragmentation pattern in parallel, and the major frag-
ments are ions at m/z = 86 u (C5H12N
+) and m/z = 58 u
(C3H8N
+). These can clearly be seen in the mass
spectrum in Figure 1 A1. The phosphatidylcholine
signal and the signals of its fragments are normally
homogenously distributed across the cell surface. Figure 1C
shows the distribution of the ions m/z = 184 u, 86 u and
58 u on a sample area which represents the same spot as
in the microscope image in Figure 1B. In the microscope
image the cells are shown in white and the uncovered
cement in grey. In the SIMS mass images the intensity of
the pixels correlate with the intensity of the mass signal. A
bright pixel indicates high intensity of the signal; a dark
pixel indicates low intensity. The mass image of the cell
signals matches the microscope image. Thus it is possible
to evaluate space-resolved information about the samplegiven by the distribution of the mass signals. As the bio-
material contains calcium and strontium we find these
cations and related species in the spectrum (Figure 1 A1).
Figure 1 A2 shows the typical pattern of the isotope distri-
bution of strontium, which supports the assumption that
the mass signal m/z = 87.9 u represents strontium. In
Figure 1D the distribution of calcium ions is shown. The
calcium image is a negative to the cell signal image, as we
only measured the first monolayers of the sample surface
(static mode). The distribution of the strontium signals,
shown in Figure 1E, is equal to the distribution of the cal-
cium signals (Figure 1D), but the intensity is much lower,
as the concentration of strontium in the S100 biomaterial
is less than of the calcium.
Investigation of the mECM on different bone cements
In the following, two different strontium enriched bone
cements are compared with pure calcium phosphate ce-
ment (CPC) as control. The strontium enriched bone
cements S100 and A10 differ in the distribution of
strontium (II) on the cement surfaces as can be seen in
Figure 2. A homogenous substitution of Ca2+- by Sr2+-
ions could be obtained in the case of the new biomaterial
S100 (Figure 2C). The new bone cement A10 is character-
ized by SrCO3 clusters (size about 30 μm), embedded in a
Sr-free cement matrix (Figure 2B). The differences of the
two Sr-enriched biomaterials result from the two different
preparation methods [19]. Virtually no strontium was
detected on the surface of the pure CPC (Figure 2A).
Osteogenically differentiated hMSCs were cultured on the
three different bone cements. To compare the chemical
information of the mineralized extracellular matrix
(mECM), synthesized by the osteoblast-like cells, the same
spot of the sample was imaged using the microscope and
the ToF-SIMS. Representative pairs of images for every
material are shown in Figure 3. The first row of Figure 3
(A-C) shows the microscope images, and in the second
row (Figure 3D-F) the corresponding ToF-SIMS overlays
of mass images are depicted. As before, in the microscope
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Figure 1 Mass spectra (A1 and A2), optical image (B) and SIMS mass images (C-E) of strontium substituted calcium phosphate cement
cultured with hMSCs in osteogenic differentiation medium for one day (S100 1d). Figure A1 shows the labeled masses which were used to
generated the SIMS mass images. A typical mass pattern of the strontium isotopes is shown in Figure A2. The spatial distribution of the cell mass
signals (C), calcium signals (D) and strontium signals (E) are shown in the SIMS mass images. The spatial patterns of mass signals offer the same
morphological information as the microscope image (B), in which the cells are shown in white and the S100 cement in grey.
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covered cement in grey and the mineralized extracellular
matrix (mECM) is shown in black. In the ToF-SIMS
overlays the cell mass signal C3H8N
+ is shown in red,
the calcium signal in blue and the strontium signal in
green. The cell mass signals in the SIMS mass imagesexhibit the same shape as the white spots in the micro-
scope images, which represent the cells. The calcium
signal is found in the regions of the uncovered cement
surface and the mECM. In comparison to the control
group (CPC, Figure 3D) a very high strontium signal is
observed in the region of the mECM in the ToF-SIMS
Sr+ Sr+ Sr+
A B C
S100CPC A10
MC: 2    TC:5.3 E+02 MC: 80   TC: 5.7 E+04 MC: 80   TC: 8.7 E+05
Figure 2 Strontium distribution on the surface of three biomaterials CPC (A), A10 (B) and S100 (C). For B and C the same intensity scale
was used.
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weak Ca signal is detected in the mECM due to the low
calcium concentration. But it is found that the intensities
of calcium and strontium are not homogenously distrib-
uted over the different spots of the mECM. Until know
we have no explanation for this finding. In the case ofFigure 3 Light optical microscope images (A-C) and SIMS mass image
hMSCs cultured for 21 days on three different bone cements (CPC m,
white, the uncovered cements in grey and the mECM in black (A-C). In the
calcium signal in blue and the strontium signal in green (D-F).the pure CPC and A10 a high intensity of the Ca-signal
was observed in the region of the mECM. Here stron-
tium was only found in a few spots of the mECM, and if
so, only a very low intensity of strontium was detected
(Figure 3D-E). In the case of the strontium enriched
biomaterials previous study showed that strontium iss (D-E) of the mECM synthesized by osteogenically differentiated
A10 m, S100 m). In the microscope images the cells are shown in
SIMS images the cell mass signal (C3H8N)
+ is shown in red, the
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indicates that the cells used most likely the free Sr2+-ions
in the medium to build up their mECM. Since the A10
samples are characterized by an inhomogeneous distribu-
tion of strontium the cells are exposed to different stron-
tium concentrations. Therefore strontium could be found
in only a small number of matrix nodules.
Previous studies have shown that strontium is incor-
porated in the matrix nodules after cells were cultured
with strontium salts [11]. How the strontium uptake in
the mECM takes place is still unknown. It seems likely
that the strontium ion reacts like the calcium ion. Vari-
ous mechanisms how calcium is taken up into the min-
eralized extracellular matrix have been postulated: i) a
cell-independent process where collagen associates with
noncollagenous proteins to produce native fibrils, which
mediate mineral nucleation [34]; ii) a cell-controlled
mechanism by which Ca2+ and phosphate ions are accu-
mulated in matrix-vesicles extracellulary or iii) calcium
and amorphous calcium phosphate are stored inside the
cells and transported via vesicles to the ECM [35]. The
same mechanisms may be responsible for the incorpor-
ation of strontium into the mECM. As there is no native
storage of strontium inside the cell, it is more likely that
strontium is incorporated extracellulary into the mECM
due to a Ca/Sr exchange.
Monitoring the strontium signal inside the cells
In a next step we compared the strontium content inside
the osteogenically differentiated hMSCs cultured on the
strontium enriched bone cements with cells cultured on
the pure calcium phosphate cement (CPC) and the sili-
con wafer (Si21d). To analyze the strontium distribution
inside the cells a sputter gun was used to remove the cell
layer by layer. Between the sputter cycles the exposed
surfaces were analyzed using the primary ion gun. Since
cells are not planar and as the sputter gun was arranged
at a 45° angle to the sample various removal rates were
obtained from different spots on the sample. Therefore
the thinner parts of the cell are earlier removed com-
pletely than the thicker parts.
A depth profile of an osteoblast-like cell cultured on
S100 cement for 21 days and relocated afterwards by
trypsination and subsequent re-seeding on a silicon
wafer (S100 r) can be seen in Figure 4A. The intensities
of the signals are shown for the cell thickness of 280 nm
and summed up over the analyzed area which can be
seen in Figure 4C-E. As the cells were relocated on sili-
con wafer the Si-signal increases with sputter time and
remains nearly constant after 300 s of the depth profile
measurement. During the first seconds of sputtering a
decrease of the cell signal was observed, which indicates
that the phospholipid membrane had been removed.
After entering the interior of the cell an increase of boththe strontium and the calcium signal were found. Both
signals remain fairly constant until the silicon wafer is
reached, then the signals of Sr+ and Ca+ decrease again.
It is known that oxygen sputtering can cause sample
degradation which leads to fragmentation of the organic
compounds during depth profiling. This can also explain
the loss of the lipid signal in the depth profile in Figure 4A.
In the mass spectrum of the last 100 s of the depth profile
the signal of C3H8N
+ and also other organic compounds
like C3H3O
+ are still observed (Additional file 2). There-
fore the lateral distribution of the cell signal C3H8N
+
during the depth profile is shown in Figure 4D. For better
comparison the total ion image is shown in Figure 4C.
The distribution of the strontium signal can be seen in
Figure 4E. In these SIMS mass images the intensities
obtained at different z-values are summed up, i.e. the im-
ages represent depth integrals. The strontium signal is
found in the same region as the cell signal. As strontium
could be detected over the whole depth profile and could
not be detected in the outer part of the cell this indicates
that strontium is uniformly distributed inside the cell.
To confirm the assumption that strontium has indeed
moved into the cell a 3D reconstruction including a z-
correction [32] from the SIMS data of the depth profile
was made. The distribution of the strontium signal
(green) and the summed cell signals of C3H8N
+, C5H12N
+
and C5H15PNO4
+ (red) are shown in Figure 4B. Due to
the O2
+ - sputtering the cell signals are unfortunately too
weak to reconstruct the whole cell membrane. But we col-
lected still enough signal intensity to estimate the shape of
the cell. From this 3D illustration it can also be concluded
that the strontium signal is only distributed inside the cell.
For further data evaluation only the 2D images were used
since the same interpretation can be achieved with a better
validity. In Figure 5D the strontium distribution inside a
cell cultured on the strontium enriched calcium phosphate
cement A10 can be seen. The same distribution of stron-
tium in the cell could be observed. This indicates that
strontium released by the cements can enter the cells.
As can be seen in Figure 5, strontium was also
detected inside the cells of the control groups, relocated
cells from the pure CPC (CPC r, Figure 5E) and within
cells cultured on the silicon wafer (Si21d, Figure 5F). No
strontium was added to the osteogenic differentiation
medium of all samples and no Sr could be detected by
AAS (atomic absorption spectroscopy) in the purchased
and standardized medium (data not shown). But stron-
tium is a trace element and appears often with calcium. It
also occurs in enzymes, which might be the reason why
strontium was found in the negative control groups as
well (Figure 5E-F). The strontium content in hMSCs of
three different patients cultured for one day was analyzed.
Therefore three cells of each donor were depth profiled.
For data evaluation the same area size of region of interest
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Figure 4 3D analysis of an osteogenically differentiated hMSC. (A) depth profile of an osteogenically differentiated hMSC cultured on S100
relocated after 21 days on a silicon wafer(S100 r). The signal intensity is shown over the whole analysis area. The estimated thickness of the cell is
280 nm. (B) 3D reconstruction of the depth profile showing the distribution of strontium and the cell signals C3H8N
+, C5H12N
+ and C5H15PNO4
+.
The value of the z axis has no physical meaning and depends on the number of layers in the 3D profile. The SIMS mass images show the lateral
distribution summed over the whole depth profile of the total ions (C), cell mass signal C3H8N
+ (D) and the strontium signal (E).
Kokesch-Himmelreich et al. Biointerphases 2013, 8:17 Page 8 of 12
http://www.biointerphases.com/content/8/1/17was used. In Figure 6 it can be seen that the intensity of
the strontium signals differs, so it can be suggested that
the strontium content inside the cells depends on the cell
donor. The cells in Figures 5 and 7 belong to the same
donor. The cells investigated in Figure 6 were chosen from
random donors to demonstrate the high variance between
cells from different donors.
After 21 days of cultivation the strontium concentra-
tion inside the cells might be lower as in the cells whichwere only cultured for one day due to the proliferation.
In Figure 5F the strontium content in the cells cultured
on a silicon wafer for 21 days is almost as high as in the
cells, cultivated on A10 (5D). This leads to the assump-
tion that strontium is accumulated in the cells. However,
to compare the strontium content in the cells cultured
on the different biomaterials and substrates the hMSCs
from the same donor were used. Again three cells on
each type of substrate were measured. The strontium
Figure 5 SIMS mass images of the cell signals (A-C) and strontium signals (D-F) of osteoblast-like cells. Cells were cultured in osteogenic
differentiation medium on A10 and on the control groups CPC cement and silicon wafer (Si 21d). Cells cultured on the cements were relocated
on a silicon wafer afterwards (A10 r, CPC r). For each mass signal of the different samples the same intensity scale was used.
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http://www.biointerphases.com/content/8/1/17peak areas of the mass spectra of the different samples
are compared in Figure 7A. The highest strontium con-
tent was found in the osteoblast-like cells cultured on
the strontium enriched cements (S100 r and A10 r), and
the lowest was found in the cells cultured for 21 days on
a silicon-wafer (Si21d). A high variation in the strontium
content of the A10 cells could be observed. As only
three cells were measured the inhomogeneity of the A10
cement sample could cause such variation. In the case of
the biomaterials the cells were relocated after 21 days on
silicon wafers. Only perfectly adherent cells were chosen
for depth profiling but as the relocated cells were no
longer exposed to additional strontium, and the reloca-
tion causes stress for the cells the real strontium contentSi 1d a0
(p
ea
k a
re
a /
 to
tal
 co
un
ts)
Si 1d b Si 1d c
Figure 6 Strontium content in the hMSCs cultured on silicon
wafers for one day from three different cell donors (Si 1d a, b, c).
Data are expressed as the mean ± standard deviation (n = 3).could be different afterwards. To investigate the influence
of the relocation, osteoblast-like cells were cultured with
1.0 mM SrCl2 for 21 days and one load was relocated
afterwards by trypsination and subsequent re-seeding on a
silicon wafer (SrCl2 1.0 r). To clarify whether the intensity
of the strontium signal as obtained with ToF-SIMS can be
used as a measure of the strontium concentration; cells
were cultured on silicon wafers with two different SrCl2
concentrations. The strontium content inside the cells of
these control groups can be seen in Figure 7B. There is a
large difference between the strontium intensity of the
cells cultured with 0.1 mM and 1.0 mM SrCl2. This dia-
gram indicates that it is possible to detect the comparative
difference of strontium contents inside the cells, which
were exposed to different strontium concentrations via
ToF-SIMS. Furthermore it proves that the strontium
content in cells will be higher if the cells are exposed to
a higher concentration of strontium. The strontium
content in the relocated cells (SrCl2 1.0 r) is much lower
than in the original sample (SrCl2 1.0). The relocation
of the cells influences the strontium signal. That means
that the original strontium content of the cells cultured
on the cements could be much higher than it is
observed in Figure 7A.
However, strontium could be found in the mineralized
extracellular matrix (mECM) synthesized by the osteoblast-
like cells cultured on the cements and strontium could be
detected in the osteoblast-like cells of every sample type.
But a clear difference in the amount of strontium could be
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Figure 7 Sr content in osteogenically differentiated hMSCs.
(A) Strontium content in osteogenically differentiatedhMSCs from
the same donor as in Figures 4 and 5 cultured onthe three different
bone cements (CPC r, B10 r, S100 r) and ona silicon wafer for 21
days (Si 21d). (B) Strontium content in osteogenically differentiated
hMSCs cultured on silicon wafers for 21 days with SrCl2 in the
growth medium. The first and second column show the Sr content in
cells cultured with 0.1 mM and 1.0 mM SrCl2, respectively in the
medium. The third column shows the Sr content in cells, which were
relocated after 21 days with 1.0 mM SrCl2 in the medium (SrCl2 r). Data
are expressed as the mean ± standard deviation (n = 3).
Kokesch-Himmelreich et al. Biointerphases 2013, 8:17 Page 10 of 12
http://www.biointerphases.com/content/8/1/17observed. The higher the strontium concentration in the
medium the higher the intensity of the strontium signals
in the osteoblast-like cells and in the mECM. The mech-
anism of the strontium incorporation into the mECM
cannot be clarified from this study. Therefore further
biomolecular investigations are necessary. As men-
tioned before strontium enhances the replication and
differentiation of pre-osteoblastic cells and the activity
of functional osteoblasts. Due to that the rate of bone
matrix synthesis increases [9]. The molecular targets
of strontium are still being investigated. As strontium
is a divalent ion and chemically close to Ca2+, Sr2+
may act on similar cellular targets as the calcium ion
[36]. In the case of calcium the uptake into osteoblasts
takes place due to different families of calcium ion chan-
nels inside the phospholipid membrane [37]. As the ionic
radius of strontium is twice that of calcium, it is more
likely that strontium passes the membrane using one of
the non-selective ion channels. It was demonstrated that
strontium plays an important role in signaling pathways in
osteoblasts. On the one hand it activates the calcium sen-
sor receptor (CaSR) [38] on the other hand strontium isinvolved in the Wnt signaling pathway. These combined
interactions of Sr2+ result in increased osteoblastic
cell replication, osteoblast gene expression and cell
survival [36]. These beneficial effects on the osteo-
blasts depend on the concentration of the strontium
ions inside the cells. A high strontium concentration
leads to a high impact on the signaling pathways. As
the strontium content inside the cells cultured on the
strontium enriched biomaterials was higher than in
the control groups the newly developed calcium phos-
phate cements S100 and A10 are promising implant
materials for the use in systemically altered bone.
Conclusion
It was previously shown that newly developed stron-
tium enriched bone cements release strontium to the
medium [19]. Here we could demonstrate that the re-
leased strontium is incorporated into the mineralized
extracellular matrix (mECM) as well as enriched inside
the osteogenically differentiated hMSCs. In comparison
to the control group we detected a definitely higher
amount of strontium in the mECM of the osteoblast-
like cells cultured on the strontium substituted bone
cement S100. The present data are in accordance with
previous studies showing that strontium is incorporated
in the mECM [11] and in newly formed human bone
[39]. Our results prove that strontium ions from artifi-
cial biomaterials indeed pass the cellular membrane
and accumulate inside the osteoblast-like cells. The
strontium was found to be uniformly distributed in the
interior of the cells. The strontium content inside the
cells cultured on the strontium enriched bone cements
is much higher than in cells cultured on the control
groups. As strontium is known for its beneficial effect
on osteoblasts the strontium release is a promising
property of the strontium enriched calcium phosphate
cements for their use as an implant material for
osteoporotic bone. In contrast to the A10 samples a
homogenous distribution of Sr2+-ions could be
obtained in the S100 samples. Therefore the osteoblast-
like cells cultured on the S100 biomaterial are exposed
to the same Sr concentration. This results in a higher
strontium concentration in the osteoblast-like cells,
cultured on the S100 biomaterial and in their mECM.
In conclusion, the strontium substituted calcium phos-
phate cement S100 could be proposed as a promising
biomaterial for the treatment of bone defects in osteo-
porotic patients.
Additional files
Additional file 1: A) 3D profile of a cell cultured on S100 for 21 days
and relocated to a silicon wafer obtained by the PLu neox 3D
optical profiler before the cell was depth profiled with ToF-SIMS.
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http://www.biointerphases.com/content/8/1/17B) 3D reconstruction of the same cell as in A) using SIMS data. C) 2D
image in false color map of the same cell. The black line indicates the
position of the corresponding z profile in D). To compare the 3D profiles
obtained with different analytical methods we have to take into account
that we cannot proper scale the z axis of the SIMS depth profile with the
applied software tool and it is difficult to look at the exact same cross-
section of the cell. Considering these facts the 3d profiles look nearly the
same. This leads us to the assumption that rarely differential sputtering
occurs.
Additional file 2: Mass spectra of the last 100 s of a depth profile
from a cell cultured on S100 for 21 days and relocated to a silicon
wafer. Organic compounds like the C3H3O
+ ion, which is most likely a
fragment of an amino acid can still be observed.Competing interests
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